Xeris Biopharma Holdings, Inc. (XERS) › Capital ExpendituresXeris Biopharma Holdings, Inc. (XERS) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2020: $377.0K2021: $1.08M$1.08M2020Capital Expenditures (USD)2021Fiscal YearCapital ExpendituresChange YoY2021$1.08M+187.8%2020$377.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share